SHR-7631
/ Jiangsu Hengrui Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 3
Of
3
Go to page
1
June 13, 2025
The Clinical Study of SHR-7631 for Injection in Patients With Advanced Solid Tumors
(clinicaltrials.gov)
- P1 | N=76 | Completed | Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd. | Recruiting ➔ Completed | N=150 ➔ 76 | Trial completion date: Apr 2027 ➔ Mar 2025 | Trial primary completion date: Apr 2026 ➔ Mar 2025
Enrollment change • Trial completion • Trial completion date • Trial primary completion date • Solid Tumor
August 06, 2024
The Clinical Study of SHR-7631 for Injection in Patients With Advanced Solid Tumors
(clinicaltrials.gov)
- P1 | N=150 | Recruiting | Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd. | Not yet recruiting ➔ Recruiting
Enrollment open • Metastases • Oncology • Solid Tumor
April 24, 2024
The Clinical Study of SHR-7631 for Injection in Patients With Advanced Solid Tumors
(clinicaltrials.gov)
- P1 | N=150 | Not yet recruiting | Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Metastases • New P1 trial • Oncology • Solid Tumor
1 to 3
Of
3
Go to page
1